Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Paterson

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Genetic Epidemiology|December 22, 1999
Evaluation of the contribution of environmental factorsG A Darlington, J Shin, A D Paterson, et al.
European Journal of Pharmacology|March 15, 1995
Long-term haloperidol elevates dopamine D4 receptors by 2-fold in ratsO Schoots, P Seeman, H C Guan, et al.
Annals of Human Genetics|June 9, 2006
Effect of environmental factors and gender on the heritability of bone mineral density and bone sizeM Y M Ng, P C Sham, A D Paterson, et al.
The American Journal of Pathology|June 8, 2001
Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasiaA Bourdeau, M E Faughnan, M L McDonald, et al.
Pediatric Diabetes|January 29, 2008
Very high and increasing incidence of type 1 diabetes mellitus in Newfoundland and Labrador, CanadaL A Newhook, M Grant, S Sloka, et al.
Metabolic Bone Disease & Related Research|January 1, 1981
Paget's disease: improvement of spinal cord dysfunction with diphosphonates and calcitoninD L Douglas, J A Kanis, T Duckworth, et al.
Lancet (London, England)|February 7, 1987
Causes of death in diabetic patients with impaired renal function. An audit of a hospital diabetic clinic populationA D Paterson, T L Dornan, I Peacock, et al.
Genes and Immunity|June 13, 2014
Genetic dissection of Iddm26 in the spontaneously diabetic BBDP ratJ Sarmiento, R H Wallis, T Ning, et al.
Lancet (London, England)|October 21, 1995
Genetic variation of 5-HT2A receptor and response to clozapineM Masellis, A D Paterson, F Badri, et al.
Pharmacogenetics|July 18, 2000
Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration methodV Ozdemir, W Kalow, B K Tang, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Genetic Epidemiology|December 22, 1999
Evaluation of the contribution of environmental factorsG A Darlington, J Shin, A D Paterson, et al.
European Journal of Pharmacology|March 15, 1995
Long-term haloperidol elevates dopamine D4 receptors by 2-fold in ratsO Schoots, P Seeman, H C Guan, et al.
Annals of Human Genetics|June 9, 2006
Effect of environmental factors and gender on the heritability of bone mineral density and bone sizeM Y M Ng, P C Sham, A D Paterson, et al.
The American Journal of Pathology|June 8, 2001
Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasiaA Bourdeau, M E Faughnan, M L McDonald, et al.
Pediatric Diabetes|January 29, 2008
Very high and increasing incidence of type 1 diabetes mellitus in Newfoundland and Labrador, CanadaL A Newhook, M Grant, S Sloka, et al.
Metabolic Bone Disease & Related Research|January 1, 1981
Paget's disease: improvement of spinal cord dysfunction with diphosphonates and calcitoninD L Douglas, J A Kanis, T Duckworth, et al.
Lancet (London, England)|February 7, 1987
Causes of death in diabetic patients with impaired renal function. An audit of a hospital diabetic clinic populationA D Paterson, T L Dornan, I Peacock, et al.
Genes and Immunity|June 13, 2014
Genetic dissection of Iddm26 in the spontaneously diabetic BBDP ratJ Sarmiento, R H Wallis, T Ning, et al.
Lancet (London, England)|October 21, 1995
Genetic variation of 5-HT2A receptor and response to clozapineM Masellis, A D Paterson, F Badri, et al.
Pharmacogenetics|July 18, 2000
Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration methodV Ozdemir, W Kalow, B K Tang, et al.
Pageof 9